These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24001541)

  • 1. Author reply: To PMID 23415776.
    Sharma N; Goel M; Bansal S; Agarwal P; Titiyal J; Upadhyaya A; Vajpayee R
    Ophthalmology; 2013 Sep; 120(9):e62. PubMed ID: 24001541
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoroquinolones in corneal ulcers.
    Galvis V; Tello A; Guerra AR; Acuña MF; Villarreal D
    Ophthalmology; 2013 Sep; 120(9):e61-2. PubMed ID: 24001539
    [No Abstract]   [Full Text] [Related]  

  • 3. Monotherapy versus fortified antibiotics for bacterial keratitis.
    Rosenberg JB; Gritz DC
    Cornea; 2011 Sep; 30(9):1066; author reply 1066-7. PubMed ID: 21775886
    [No Abstract]   [Full Text] [Related]  

  • 4. Moxifloxacin for bacterial keratitis.
    Rosenberg J; Eisen L; Kim J
    Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
    Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
    Baker RS; Flowers CW; Casey R; Fong DS; Wilson MR
    Arch Ophthalmol; 1996 May; 114(5):632-3. PubMed ID: 8619784
    [No Abstract]   [Full Text] [Related]  

  • 8. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Bashir H; Dave A; Mathur U
    Cornea; 2016 Aug; 35(8):e22-3. PubMed ID: 27227400
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
    Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR
    Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
    Jhanji V; Sharma N; Satpathy G; Titiyal J
    J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual recovery in treated bacterial keratitis.
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Ray KJ; Zegans ME; Acharya NR; Lietman TM; Keenan JD;
    Ophthalmology; 2014 Jun; 121(6):1310-1. PubMed ID: 24612976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increasing problem of antibiotic resistance.
    Mamalis N
    J Cataract Refract Surg; 2007 Nov; 33(11):1831-2. PubMed ID: 17964369
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply: To PMID 24054967.
    Matsuura K; Miyoshi T; Suto C; Akura J; Inoue Y
    J Cataract Refract Surg; 2014 Mar; 40(3):509. PubMed ID: 24581786
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty.
    Srinivasan S; McAllum P; Poutanen SM; Slomovic AR
    J Cataract Refract Surg; 2006 Dec; 32(12):2149-52. PubMed ID: 17138001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.
    Munir WM; Rosenfeld SI; Udell I; Miller D; Karp CL; Alfonso EC
    Cornea; 2007 Jun; 26(5):621-4. PubMed ID: 17525664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas keratitis after laser in situ keratomileusis.
    Sharma N; Sinha R; Singhvi A; Tandon R
    J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.